5-157037250-T-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001173393.3(HAVCR1):āc.949A>Gā(p.Lys317Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000148 in 1,516,428 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001173393.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HAVCR1 | NM_001173393.3 | c.949A>G | p.Lys317Glu | missense_variant | 7/9 | ENST00000523175.6 | NP_001166864.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HAVCR1 | ENST00000523175.6 | c.949A>G | p.Lys317Glu | missense_variant | 7/9 | 1 | NM_001173393.3 | ENSP00000427898.1 |
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 152168Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000144 AC: 36AN: 249414Hom.: 1 AF XY: 0.000177 AC XY: 24AN XY: 135322
GnomAD4 exome AF: 0.000152 AC: 208AN: 1364260Hom.: 1 Cov.: 22 AF XY: 0.000158 AC XY: 108AN XY: 684458
GnomAD4 genome AF: 0.000105 AC: 16AN: 152168Hom.: 0 Cov.: 32 AF XY: 0.000121 AC XY: 9AN XY: 74328
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 17, 2022 | The c.949A>G (p.K317E) alteration is located in exon 6 (coding exon 6) of the HAVCR1 gene. This alteration results from a A to G substitution at nucleotide position 949, causing the lysine (K) at amino acid position 317 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at